Sign In
Buy LLY
$1,116.11
-5.06 (-0.451%)
At Close: Aug 04, 2026
5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX
04:02am, Tuesday, 30'th Jun 2026
Investors rushed to get in on SpaceX's IPO -- and benefit from the company's innovation and growth. Eli Lilly's strength in the high-growth weight loss drug market has supercharged revenue.
China's Innovent Biologics gains commercialization rights for Eli Lilly breast cancer drug
01:57am, Tuesday, 30'th Jun 2026
Innovent Biologics has entered into an agreement that grants it sole commercialization rights for Eli Lilly's breast cancer drug Verzenios in mainland China, the Chinese dru
Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
12:00am, Tuesday, 30'th Jun 2026
SAN FRANCISCO and SUZHOU, China, June 30, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commerciali
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
06:46pm, Monday, 29'th Jun 2026
The latest trading day saw Eli Lilly (LLY) settling at $1, representing a +1.81% change from its previous close.
FDA selects Lilly, Regeneron for program to speed up review of new manufacturing facilities, CNBC reports
03:03pm, Monday, 29'th Jun 2026
The U.S. Food and Drug Administration has selected Eli Lilly and Regeneron , among seven companies, for a pilot program to accelerate reviews of new domestic pharmaceu
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
02:50pm, Monday, 29'th Jun 2026
Eli Lilly, Regeneron, Amneal, Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the FDA's PreCheck pilot program. The FDA PreCheck
Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs
12:11pm, Monday, 29'th Jun 2026
LLY, ABBV, BIIB and JNJ hit new 52-week highs as biotech rallies, with company-specific pipeline, approvals and deal activity adding momentum.
Here's Why Shares of Eli Lilly Hit an All-Time High on Friday
10:31am, Monday, 29'th Jun 2026
LLY hit a record high after a positive EU panel opinion for Jaypirca and expanded $50/month Medicare access for Zepbound and Foundayo.
Lilly (LLY) Moves 7.1% Higher: Will This Strength Last?
08:52am, Monday, 29'th Jun 2026
Lilly (LLY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the
3 Monster Stocks to Buy Right Now With Dividend Yields of 5% or More
05:55am, Monday, 29'th Jun 2026
Why settle for puny yields when you can buy these monster dividend stocks?
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
08:00am, Sunday, 28'th Jun 2026
Millions of older Americans in Medicare are about to gain access to obesity drugs through Medicare's new Bridge demonstration program for a monthly copay of just $50. But many seniors may be unaware o
Why Eli Lilly Gained 7% On Friday
06:50am, Sunday, 28'th Jun 2026
Eli Lilly saw its biggest gain of 7% in yesterday's trading session since early February, when it jumped 10% on the release of 2025 results. While LLY's gains outstripped peers, it was hardly alone in
Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates
08:00am, Saturday, 27'th Jun 2026
The top stocks flourish buy points and relative strength. Two are defensive growth names.
Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy?
08:15pm, Friday, 26'th Jun 2026
Eli Lilly (LLY +7.51%) is benefiting from its blockbuster weight loss treatment.
Why Eli Lilly Stock Jumped to a New All-Time High Today
07:14pm, Friday, 26'th Jun 2026
Eli Lilly's leukemia drug is making progress toward regulatory approval in the EU. The healthcare leader's weight-loss drugs will soon be more affordable for millions of people.
